Litcius/Paper detail

Tremelimumab: First Approval

Susan J. Keam

2022Drugs101 citationsDOIOpen Access PDF

Topics & Concepts

TremelimumabDurvalumabMedicineOncologyInternal medicineChemoprotectiveCancerImmunotherapyIpilimumabNivolumabLung Cancer Research StudiesCancer Immunotherapy and BiomarkersPancreatic and Hepatic Oncology Research